Verastem (VSTM) Accounts Payables (2011 - 2026)
Verastem (VSTM) recorded quarterly Accounts Payables of $9.6 million in Q1 2026, down 22.86% quarter-over-quarter from $12.4 million in Q4 2025, and up 33.38% on a YoY basis from $7.2 million in Q1 2025.
Verastem (VSTM) Accounts Payables (2011 - 2026) Analysis & Trends
Verastem's Accounts Payables history runs 16 years deep, the most recent figure standing at $9.6 million for Q1 2026.
- In Q1 2026, Accounts Payables rose 33.38% year-over-year to $9.6 million; the TTM figure through Mar 2026 stood at $9.6 million (up 33.38% YoY), while the FY2025 annual figure was $12.4 million, up 209.19% from the prior year.
- Accounts Payables was $9.6 million for Q1 2026 at Verastem, down from $12.4 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $12.4 million in Q4 2025 to a low of $1.7 million in Q2 2022.
- Historically, Accounts Payables has averaged $6.3 million across 5 years, with a median of $5.4 million in 2022.
- The sharpest annual moves came in 2022 and 2024: Accounts Payables soared 736.04% in 2022, then plunged 43.96% in 2024.
- A 5-year view of Accounts Payables shows it stood at $4.9 million in 2022, then jumped by 46.58% to $7.2 million in 2023, then slumped by 43.96% to $4.0 million in 2024, then surged by 209.19% to $12.4 million in 2025, then declined by 22.86% to $9.6 million in 2026.
- The last three Accounts Payables figures came in at $9.6 million (Q1 2026), $12.4 million (Q4 2025), and $9.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.64 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn | 9.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.60 Mn |
| Dec 31, 2025 | 12.45 Mn |
| Sep 30, 2025 | 9.89 Mn |
| Jun 30, 2025 | 8.05 Mn |
| Mar 31, 2025 | 7.20 Mn |
| Dec 31, 2024 | 4.03 Mn |
| Sep 30, 2024 | 4.44 Mn |
| Jun 30, 2024 | 6.68 Mn |
| Mar 31, 2024 | 7.45 Mn |
| Dec 31, 2023 | 7.18 Mn |
| Sep 30, 2023 | 5.12 Mn |
| Jun 30, 2023 | 4.55 Mn |
| Mar 31, 2023 | 4.90 Mn |
| Dec 31, 2022 | 4.90 Mn |
| Sep 30, 2022 | 5.36 Mn |
| Jun 30, 2022 | 1.71 Mn |
| Mar 31, 2022 | 2.90 Mn |
| Dec 31, 2021 | 2.30 Mn |
| Sep 30, 2021 | 641,000.00 |
| Jun 30, 2021 | 1.40 Mn |